HMGB1 and neoplasm: Immunofluorescence staining revealed that Cu-DON could induce a strong ICD response in tumor cells, as evidenced by effective calmodulin (CRT) exposure and high mobility group box 1 (HMGB1) release of 4T1 cells after Cu-DON treatment, which are pivotal biomarkers of ICD (Fig. 10b).